Which breathing aid works best for kids? new study compares HVNI and CPAP

NCT ID NCT07336121

First seen Jan 24, 2026 · Last updated Jun 22, 2026 · Updated 22 times

Summary

This study looked at 80 children aged 1 month to 5 years with severe breathing problems from pneumonia or bronchiolitis. It compared two non-invasive breathing support methods: High Velocity Nasal Insufflation (HVNI) and Nasal Continuous Positive Airway Pressure (CPAP). The goal was to see which method improves lung function better and is more comfortable for children, using daily lung ultrasound scores and clinical assessments.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BRONCHIOLITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Pediatric Intensive Care Units, Children Hospital, Ain shams university

    Cairo, 00002, Egypt

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

High Velocity Nasal Insufflation (HVNI) and Nasal Continuous Positive Airway Pressure (CPAP) devices

What this could lead to

If this study shows one method is better, it could help doctors choose the most effective and comfortable breathing support for young children with breathing problems.

What could go wrong

This is a small, completed study with only 80 children, so results may not apply to all kids. The devices are already in use, so no major new risks are expected, but the study may not find a clear winner.

Conditions

The condition(s) this trial relates to.

acute respiratory distress syndrome bronchiolitis Community-Acquired Pneumonia pneumonia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.